Literature DB >> 25619230

Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program.

Thomas G Beach1, Charles H Adler2, Lucia I Sue1, Geidy Serrano1, Holly A Shill1, Douglas G Walker1, LihFen Lue1, Alex E Roher1, Brittany N Dugger1, Chera Maarouf1, Alex C Birdsill1, Anthony Intorcia1, Megan Saxon-Labelle1, Joel Pullen1, Alexander Scroggins1, Jessica Filon1, Sarah Scott1, Brittany Hoffman1, Angelica Garcia1, John N Caviness2, Joseph G Hentz2, Erika Driver-Dunckley2, Sandra A Jacobson1, Kathryn J Davis1, Christine M Belden1, Kathy E Long1, Michael Malek-Ahmadi1, Jessica J Powell1, Lisa D Gale1, Lisa R Nicholson1, Richard J Caselli2, Bryan K Woodruff2, Steven Z Rapscak3, Geoffrey L Ahern3, Jiong Shi4, Anna D Burke5, Eric M Reiman5, Marwan N Sabbagh1.   

Abstract

The Brain and Body Donation Program (BBDP) at Banner Sun Health Research Institute (http://www.brainandbodydonationprogram.org) started in 1987 with brain-only donations and currently has banked more than 1600 brains. More than 430 whole-body donations have been received since this service was commenced in 2005. The collective academic output of the BBDP is now described as the Arizona Study of Aging and Neurodegenerative Disorders (AZSAND). Most BBDP subjects are enrolled as cognitively normal volunteers residing in the retirement communities of metropolitan Phoenix, Arizona. Specific recruitment efforts are also directed at subjects with Alzheimer's disease, Parkinson's disease and cancer. The median age at death is 82. Subjects receive standardized general medical, neurological, neuropsychological and movement disorders assessments during life and more than 90% receive full pathological examinations by medically licensed pathologists after death. The Program has been funded through a combination of internal, federal and state of Arizona grants as well as user fees and pharmaceutical industry collaborations. Subsets of the Program are utilized by the US National Institute on Aging Arizona Alzheimer's Disease Core Center and the US National Institute of Neurological Disorders and Stroke National Brain and Tissue Resource for Parkinson's Disease and Related Disorders. Substantial funding has also been received from the Michael J. Fox Foundation for Parkinson's Research. The Program has made rapid autopsy a priority, with a 3.0-hour median post-mortem interval for the entire collection. The median RNA Integrity Number (RIN) for frozen brain and body tissue is 8.9 and 7.4, respectively. More than 2500 tissue requests have been served and currently about 200 are served annually. These requests have been made by more than 400 investigators located in 32 US states and 15 countries. Tissue from the BBDP has contributed to more than 350 publications and more than 200 grant-funded projects.
© 2015 Japanese Society of Neuropathology.

Entities:  

Keywords:  Alzheimer's disease; Parkinson's disease; RNA; aging; autopsy; biobank; biospecimen; brain bank; cancer; freeze-thaw; pathology; post-mortem interval

Mesh:

Substances:

Year:  2015        PMID: 25619230      PMCID: PMC4593391          DOI: 10.1111/neup.12189

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  338 in total

1.  An examination of bias in volunteer subject selection: findings from an in-depth child abuse study.

Authors:  F S Mandel; M Weiner; S Kaplan; D Pelcovitz; V Labruna
Journal:  J Trauma Stress       Date:  2000-01

2.  Ventral striatal D(3) receptors and Parkinson's Disease.

Authors:  J N. Joyce; H Ryoo; E V. Gurevich; C Adler; T Beach
Journal:  Parkinsonism Relat Disord       Date:  2001-07       Impact factor: 4.891

Review 3.  Brain banking and the human hypothalamus--factors to match for, pitfalls and potentials.

Authors:  R Ravid; E J Van Zwieten; D F Swaab
Journal:  Prog Brain Res       Date:  1992       Impact factor: 2.453

4.  Alterations in immunological and neurological gene expression patterns in Alzheimer's disease tissues.

Authors:  Ashani T Weeraratna; Audrey Kalehua; Isoke Deleon; Dorothy Bertak; Gregory Maher; Michael S Wade; Ana Lustig; Kevin G Becker; William Wood; Douglas G Walker; Thomas G Beach; Dennis D Taub
Journal:  Exp Cell Res       Date:  2006-11-01       Impact factor: 3.905

5.  Microinfarct pathology, dementia, and cognitive systems.

Authors:  Zoe Arvanitakis; Sue E Leurgans; Lisa L Barnes; David A Bennett; Julie A Schneider
Journal:  Stroke       Date:  2011-01-06       Impact factor: 7.914

6.  High total cholesterol levels in late life associated with a reduced risk of dementia.

Authors:  M M Mielke; P P Zandi; M Sjögren; D Gustafson; S Ostling; B Steen; I Skoog
Journal:  Neurology       Date:  2005-05-24       Impact factor: 9.910

Review 7.  Alzheimer's disease and the "Valley Of Death": not enough guidance from human brain tissue?

Authors:  Thomas G Beach
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

8.  A nation-wide study of atherosclerosis in infants, children and young adults in Japan.

Authors:  K Tanaka; J Masuda; T Imamura; K Sueishi; T Nakashima; I Sakurai; T Shozawa; Y Hosoda; Y Yoshida; Y Nishiyama
Journal:  Atherosclerosis       Date:  1988-08       Impact factor: 5.162

9.  Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis.

Authors:  David C Whitcomb; Jessica LaRusch; Alyssa M Krasinskas; Lambertus Klei; Jill P Smith; Randall E Brand; John P Neoptolemos; Markus M Lerch; Matt Tector; Bimaljit S Sandhu; Nalini M Guda; Lidiya Orlichenko; Samer Alkaade; Stephen T Amann; Michelle A Anderson; John Baillie; Peter A Banks; Darwin Conwell; Gregory A Coté; Peter B Cotton; James DiSario; Lindsay A Farrer; Chris E Forsmark; Marianne Johnstone; Timothy B Gardner; Andres Gelrud; William Greenhalf; Jonathan L Haines; Douglas J Hartman; Robert A Hawes; Christopher Lawrence; Michele Lewis; Julia Mayerle; Richard Mayeux; Nadine M Melhem; Mary E Money; Thiruvengadam Muniraj; Georgios I Papachristou; Margaret A Pericak-Vance; Joseph Romagnuolo; Gerard D Schellenberg; Stuart Sherman; Peter Simon; Vijay P Singh; Adam Slivka; Donna Stolz; Robert Sutton; Frank Ulrich Weiss; C Mel Wilcox; Narcis Octavian Zarnescu; Stephen R Wisniewski; Michael R O'Connell; Michelle L Kienholz; Kathryn Roeder; M Michael Barmada; Dhiraj Yadav; Bernie Devlin
Journal:  Nat Genet       Date:  2012-11-11       Impact factor: 38.330

10.  Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.

Authors:  Adam C Naj; Gyungah Jun; Gary W Beecham; Li-San Wang; Badri Narayan Vardarajan; Jacqueline Buros; Paul J Gallins; Joseph D Buxbaum; Gail P Jarvik; Paul K Crane; Eric B Larson; Thomas D Bird; Bradley F Boeve; Neill R Graff-Radford; Philip L De Jager; Denis Evans; Julie A Schneider; Minerva M Carrasquillo; Nilufer Ertekin-Taner; Steven G Younkin; Carlos Cruchaga; John S K Kauwe; Petra Nowotny; Patricia Kramer; John Hardy; Matthew J Huentelman; Amanda J Myers; Michael M Barmada; F Yesim Demirci; Clinton T Baldwin; Robert C Green; Ekaterina Rogaeva; Peter St George-Hyslop; Steven E Arnold; Robert Barber; Thomas Beach; Eileen H Bigio; James D Bowen; Adam Boxer; James R Burke; Nigel J Cairns; Chris S Carlson; Regina M Carney; Steven L Carroll; Helena C Chui; David G Clark; Jason Corneveaux; Carl W Cotman; Jeffrey L Cummings; Charles DeCarli; Steven T DeKosky; Ramon Diaz-Arrastia; Malcolm Dick; Dennis W Dickson; William G Ellis; Kelley M Faber; Kenneth B Fallon; Martin R Farlow; Steven Ferris; Matthew P Frosch; Douglas R Galasko; Mary Ganguli; Marla Gearing; Daniel H Geschwind; Bernardino Ghetti; John R Gilbert; Sid Gilman; Bruno Giordani; Jonathan D Glass; John H Growdon; Ronald L Hamilton; Lindy E Harrell; Elizabeth Head; Lawrence S Honig; Christine M Hulette; Bradley T Hyman; Gregory A Jicha; Lee-Way Jin; Nancy Johnson; Jason Karlawish; Anna Karydas; Jeffrey A Kaye; Ronald Kim; Edward H Koo; Neil W Kowall; James J Lah; Allan I Levey; Andrew P Lieberman; Oscar L Lopez; Wendy J Mack; Daniel C Marson; Frank Martiniuk; Deborah C Mash; Eliezer Masliah; Wayne C McCormick; Susan M McCurry; Andrew N McDavid; Ann C McKee; Marsel Mesulam; Bruce L Miller; Carol A Miller; Joshua W Miller; Joseph E Parisi; Daniel P Perl; Elaine Peskind; Ronald C Petersen; Wayne W Poon; Joseph F Quinn; Ruchita A Rajbhandary; Murray Raskind; Barry Reisberg; John M Ringman; Erik D Roberson; Roger N Rosenberg; Mary Sano; Lon S Schneider; William Seeley; Michael L Shelanski; Michael A Slifer; Charles D Smith; Joshua A Sonnen; Salvatore Spina; Robert A Stern; Rudolph E Tanzi; John Q Trojanowski; Juan C Troncoso; Vivianna M Van Deerlin; Harry V Vinters; Jean Paul Vonsattel; Sandra Weintraub; Kathleen A Welsh-Bohmer; Jennifer Williamson; Randall L Woltjer; Laura B Cantwell; Beth A Dombroski; Duane Beekly; Kathryn L Lunetta; Eden R Martin; M Ilyas Kamboh; Andrew J Saykin; Eric M Reiman; David A Bennett; John C Morris; Thomas J Montine; Alison M Goate; Deborah Blacker; Debby W Tsuang; Hakon Hakonarson; Walter A Kukull; Tatiana M Foroud; Jonathan L Haines; Richard Mayeux; Margaret A Pericak-Vance; Lindsay A Farrer; Gerard D Schellenberg
Journal:  Nat Genet       Date:  2011-04-03       Impact factor: 38.330

View more
  153 in total

1.  Pathological α-synuclein distribution in subjects with coincident Alzheimer's and Lewy body pathology.

Authors:  Jon B Toledo; Pallavi Gopal; Kevin Raible; David J Irwin; Johannes Brettschneider; Samantha Sedor; Kayla Waits; Susana Boluda; Murray Grossman; Vivianna M Van Deerlin; Edward B Lee; Steven E Arnold; John E Duda; Howard Hurtig; Virginia M-Y Lee; Charles H Adler; Thomas G Beach; John Q Trojanowski
Journal:  Acta Neuropathol       Date:  2015-12-31       Impact factor: 17.088

2.  Prevalence of Submandibular Gland Synucleinopathy in Parkinson's Disease, Dementia with Lewy Bodies and other Lewy Body Disorders.

Authors:  Thomas G Beach; Charles H Adler; Geidy Serrano; Lucia I Sue; D G Walker; Brittany N Dugger; Holly A Shill; Erika Driver-Dunckley; John N Caviness; Anthony Intorcia; Jessica Filon; Sarah Scott; Angelica Garcia; Brittany Hoffman; Christine M Belden; Kathryn J Davis; Marwan N Sabbagh
Journal:  J Parkinsons Dis       Date:  2016       Impact factor: 5.568

3.  Phosphorylated α-synuclein in the retina is a biomarker of Parkinson's disease pathology severity.

Authors:  Isabel Ortuño-Lizarán; Thomas G Beach; Geidy E Serrano; Douglas G Walker; Charles H Adler; Nicolás Cuenca
Journal:  Mov Disord       Date:  2018-05-08       Impact factor: 10.338

4.  Stakeholders' Perceptions and Information Needs Regarding Research Medical Donation.

Authors:  Andrew S Epstein; Jada G Hamilton; Elyse Shuk; Danielle R Romano; Kathleen Lynch; Erva Khan; Margaux Genoff; Chelsea Michael; Christine Iacobuzio-Donahue
Journal:  J Pain Symptom Manage       Date:  2019-07-11       Impact factor: 3.612

Review 5.  Alzheimer Disease: Scientific Breakthroughs and Translational Challenges.

Authors:  Richard J Caselli; Thomas G Beach; David S Knopman; Neill R Graff-Radford
Journal:  Mayo Clin Proc       Date:  2017-06       Impact factor: 7.616

6.  Isolation and characterization of antibody fragment selective for human Alzheimer's disease brain-derived tau variants.

Authors:  Lalitha Venkataraman; Ping He; Philip Schulz; Michael R Sierks
Journal:  Neurobiol Aging       Date:  2020-04-24       Impact factor: 4.673

7.  A Quantitative Analysis of Brain Soluble Tau and the Tau Secretion Factor.

Authors:  Pengcheng Han; Geidy Serrano; Thomas G Beach; Richard J Caselli; Junxiang Yin; Ningning Zhuang; Jiong Shi
Journal:  J Neuropathol Exp Neurol       Date:  2017-01-01       Impact factor: 3.685

8.  Large-scale proteomic analysis of Alzheimer's disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation.

Authors:  Erik C B Johnson; Eric B Dammer; Duc M Duong; Lingyan Ping; Maotian Zhou; Luming Yin; Lenora A Higginbotham; Andrew Guajardo; Bartholomew White; Juan C Troncoso; Madhav Thambisetty; Thomas J Montine; Edward B Lee; John Q Trojanowski; Thomas G Beach; Eric M Reiman; Vahram Haroutunian; Minghui Wang; Eric Schadt; Bin Zhang; Dennis W Dickson; Nilüfer Ertekin-Taner; Todd E Golde; Vladislav A Petyuk; Philip L De Jager; David A Bennett; Thomas S Wingo; Srikant Rangaraju; Ihab Hajjar; Joshua M Shulman; James J Lah; Allan I Levey; Nicholas T Seyfried
Journal:  Nat Med       Date:  2020-04-13       Impact factor: 53.440

9.  Increased expression of toll-like receptor 3, an anti-viral signaling molecule, and related genes in Alzheimer's disease brains.

Authors:  Douglas G Walker; Tiffany M Tang; Lih-Fen Lue
Journal:  Exp Neurol       Date:  2018-08-01       Impact factor: 5.330

10.  Cell death and survival pathways in Alzheimer's disease: an integrative hypothesis testing approach utilizing -omic data sets.

Authors:  Danielle L Brokaw; Ignazio S Piras; Diego Mastroeni; Daniel J Weisenberger; Jennifer Nolz; Elaine Delvaux; Geidy E Serrano; Thomas G Beach; Matthew J Huentelman; Paul D Coleman
Journal:  Neurobiol Aging       Date:  2020-07-03       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.